NCT00147836 - Evaluation of the Effects of Different Interventions on Glycemic Control in Newly-Diagnosed Type 2 Diabetic Patients | Biotech Hunter

Enrollment

436

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Human Insulin (Novolin-R, Novo Nordisk)

DEVICE

H-Tron Plus V100; Disetronic Medical System, Burgdorf, Switzerland

OTHER

Pre-meal

DRUG

Novolin-R

DRUG

Human Insulin NPH (Novolin-N, Novo Nordisk)

DRUG

Gliclazide (Diamicron, Servier)

DRUG

Diamicron and Glucophage

Trial Locations (1)

the first Affiliated Hospital of Sun Yat-Sen university, Guangzhou